In summary, our study demonstrated a critical role of Notch signaling in maintaining MEC stem-like cells and tumor growth and revealed that the approach of co-targeting Notch and EGFR signaling is a potential effective anti-MEC treatment. The gene discussed is EGFR; the disease is neoplasm.